Pancreatitis Trial, Recruiting (NCT07450898)

Pancreatitis Trial, Recruiting NCT07450898 Sponsor: RenJi Hospital Condition: Pancreatitis

Printed from Voxsanity (voxsanity.com.au) — NCT07450898 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years of age or older
You must have a blood clot-related condition affecting the blood vessels outside the heart and brain, which was treated with a minimally invasive procedure to remove the clot
You must have developed a painful inflammation of the pancreas within 14 days after having that clot-removal procedure
You must be willing and able to give written agreement to take part in the study

Who may not be able to join:

You may not be eligible if your pancreas inflammation has been confirmed to be caused by something other than the clot-removal procedure (such as gallstones or alcohol use)
You may not be eligible if you are unable or unwilling to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Qihong Ni, Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University

Phone: 15801900772

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07450898

Sponsor: RenJi Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatitis

Trial contact: 15801900772

More information: https://clinicaltrials.gov/study/NCT07450898

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years of age or older
You must have a blood clot-related condition affecting the blood vessels outside the heart and brain, which was treated with a minimally invasive procedure to remove the clot
You must have developed a painful inflammation of the pancreas within 14 days after having that clot-removal procedure
You must be willing and able to give written agreement to take part in the study

Who may not be able to join:

You may not be eligible if your pancreas inflammation has been confirmed to be caused by something other than the clot-removal procedure (such as gallstones or alcohol use)
You may not be eligible if you are unable or unwilling to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

RenJi Hospital

Registry

ClinicalTrials.gov

Start date

1 January 2016

Est. completion

31 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of acute pancreatitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov